Drug Trial Radar · NCT02271230
Intervention With Vitamin D and Omega-3 Supplements and Incident Heart Failure
Last checked: Nov 19, 2026Latest source record: Mar 18, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
25,871
Actual
Start
Aug 2014
Primary completion
Dec 2019
Study completion Dec 2019
Sponsor
- Lead sponsor
- Brigham and Women's HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Oct 22, 2014
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Factorial
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will examine whether an intervention with vitamin D or fish oil supplements can reduce the risk of heart failure among adult men and women during a follow up period of up to five years (starting from the time of randomization into the parent VITAL trial). The investigators hypotheses are that both vitamin D and fish oil supplements will each reduce the risk of heart failure.
Conditions
- Heart Failure
Interventions
Vitamin D and fish oilDrug
2000 IU vitamin D and 1g/d fish oil
Fish oil (EPA/DHA) aloneDietary supplement
1 g/d fish oil
Vitamin D aloneDrug
2000 IU vitamin D
PlaceboOther
Vitamin D placebo and fish oil placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With New Heart Failure HospitalizationTime frame: 5 years
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Brigham and Women's Hospital
Boston, Massachusetts
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.